We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0IBR market cap is 12.89B. The company's latest EPS is USD 112.9150 and P/E is 15.37.
| Year End 31 October 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.29M | 798k | 5.28M | 19.25M | 21.67M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 338.3M | -86.32M | -1.36B | -746.28M | 838.28M |
| Year End 31 October 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 420.23M | 846.21M | 1.37B | 917.6M | 1.12B |
| Total Liabilities | 127.93M | 73.41M | 208.46M | 240.1M | 231.26M |
| Total Equity | 292.3M | 772.8M | 1.16B | 677.51M | 887.43M |
| Year End 31 October 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 12.89B |
| Price to Earnings Ratio | 15.37 |
| Price to Sales Ratio | 594.68 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 14.52 |
| Dividend Yield | - |
| Shares Outstanding | 7.42M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 1,735.80 |
| 52 Week Low | 1,735.80 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Direxion Daily S&p Biotech Bull 3x |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
